Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study

Publication date: August 2020Source: IJC Heart & Vasculature, Volume 29Author(s): Sarah Berlin, Andreas Goette, Luciana Summo, Janine Lossie, Alexander Gebauer, Naab Al-Saady, Leonardo Calo, Gerald Naccarelli, Wolf-Hagen Schunck, Robert Fischer, A.John Camm, Dobromir Dobrev
Source: IJC Heart and Vasculature - Category: Cardiology Source Type: research